Annual General Meeting

Please select...

GlaxoSmithKline plc (‘GSK’) holds an Annual General Meeting in London each year during May. All the directors able to attend are available formally during the meeting, and informally beforehand, for questions.

Voting on all resolutions put to the Annual General Meeting is done by way of a poll rather than by a show of hands.

2018 Annual General Meeting

The eighteenth Annual General Meeting (‘AGM’) of GSK will be held on Thursday 3 May 2018 at 2.30pm at the QEII Centre, Broad Sanctuary, Westminster, London SW1P 3EE.

The 2018 Notice of AGM (PDF) gives details on the resolutions to be put to the meeting, together with explanatory notes.

At the AGM, a resolution will be put to shareholders to approve the adoption of new Articles of Association. GSK’s current Articles of Association can be downloaded here (PDF). The new Articles of Association, marked up to show the proposed changes, can be downloaded here (PDF).

Download details on how to requisition a resolution for GSK’s 2018 Annual General Meeting (PPT).

In accordance with section 311A of the Companies Act 2006, GSK confirms that, as at 28 March 2018, its issued share capital (excluding Treasury shares) consisted of 4,958,943,485 ordinary shares of 25 pence each, carrying one vote each. Therefore, the total voting rights that members are entitled to exercise at the AGM in respect of these shares is 4,958,943,485.

Information about our previous Annual General Meetings is available from the AGM archive tab above.

Notice of Availability

Read our Annual Summary 2017 (PDF)

2018 General Meeting – Proposed buyout of Novartis’ interest in GlaxoSmithKline Consumer Healthcare Holdings Limited

Information on the General Meeting convened for Thursday 3 May 2018 (immediately following the AGM) can be found here

Back to top